LAS VEGAS, Aug. 18, 2023 /PRNewswire/ — JanOne (Nasdaq: JAN) (the “Company”), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for underlying causes of pain, today announced that it has entered into a definitive securities purchase…